Key result
Urinary methoxycatecholamines, CT, and MIBG scintigraphy provide the most reliable diagnosis and localization of pheochromocytoma.
Observational (n=110)
Answers are grounded in this paper and cite their sources.
In 110 patients the diagnosis of pheochromocytoma was established by biochemical tests. These patients displayed various patterns of urinary and plasma catecholamines and their metabolites. The estimation of urinary methoxycatecholamines proved the most useful screening procedure. In patients with equivocal biochemical results the clonidine suppression test appeared to be a useful diagnostic tool. Clinical analysis displayed a bizzare course and unusual symptoms and signs in some patients. Computerized tomography and adrenal scintigraphic imaging with 131I-meta-iodobenzylguanidine were found to be the most reliable noninvasive methods for localization of the tumor.
No takes yet. Share an insight, caveat, or question.
Januszewicz et al. (2008) conducted an observational in Pheochromocytoma (n=110). Biochemical screening (urinary methoxycatecholamines, clonidine suppression test) and imaging localization (CT, 131I-MIBG scintigraphy) was evaluated on Diagnostic utility of biochemical tests and noninvasive localization of pheochromocytoma. Urinary methoxycatecholamines, CT, and 131I-MIBG scintigraphy were the most reliable screening and localization tools across 110 patients with pheochromocytoma.
Synapse has enriched 10 related papers. Consider them for comparative context: